Search Results

There are 10695 results for: content related to: Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial

  1. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  2. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  3. You have free access to this content
    Poster Session 4: Hepatitis C: New Agents (Not Approved)

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1128A–1161A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27533

  4. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue s2, May 2012, Pages: 1–26, I. M. Jacobson, J.-M. Pawlotsky, N. H. Afdhal, G. M. Dusheiko, X. Forns, D. M. Jensen, F. Poordad and J. Schulz

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01590.x

  5. You have free access to this content
    A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results

    Hepatology

    Volume 50, Issue 3, September 2009, Pages: 717–726, Yves Benhamou, Nezam H. Afdhal, David R. Nelson, Mitchell L. Shiffman, Deanine G. Halliman, Jamie Heise, Eric Chun and Paul J. Pockros

    Version of Record online : 11 MAY 2009, DOI: 10.1002/hep.23073

  6. You have free access to this content
    Posters (Abstracts 264–2239)

    Hepatology

    Volume 66, Issue S1, October 2017, Pages: 149–1185,

    Version of Record online : 1 OCT 2017, DOI: 10.1002/hep.29501

  7. You have free access to this content
    JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2014 Update for Genotype 1

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 59–70, Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12272

  8. You have free access to this content
    Poster Session IV (Abstracts 1638 – 2112)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 811–1050,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28800

  9. Therapy for hepatitis C genotype 3: moving forward

    Journal of Viral Hepatitis

    Volume 22, Issue 9, September 2015, Pages: 683–690, M. Buti, J. Llaneras, M. Riveiro-Barciela and R. Esteban

    Version of Record online : 13 MAY 2015, DOI: 10.1111/jvh.12419

  10. You have free access to this content
    Administration of low-dose epoetin-alpha facilitates adherence to ribavirin in triple therapy with pegylated interferon-alpha-2b and telaprevir

    Hepatology Research

    Volume 44, Issue 10, October 2014, Pages: E84–E91, Hisashi Ishida, Sadatsugu Sakane, Takashi Toyama, Keisuke Fukutomi, Keiichi Kimura, Aya Sugimoto, Kenji Hibino, Takeshi Tamura, Tetsuya Iwasaki, Ryuichiro Iwasaki, Hiroko Hasegawa, Yuko Sakakibara, Takuya Yamada, Shoichi Nakazuru and Eiji Mita

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12224

  11. You have free access to this content
    The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C

    Hepatology

    Volume 55, Issue 3, March 2012, Pages: 749–758, Stefan Zeuzem, Peter Buggisch, Kosh Agarwal, Patrick Marcellin, Daniel Sereni, Hartwig Klinker, Christophe Moreno, Jean-Pierre Zarski, Yves Horsmans, Hongmei Mo, Sarah Arterburn, Steven Knox, David Oldach, John G. McHutchison, Michael P. Manns and Graham R. Foster

    Version of Record online : 23 FEB 2012, DOI: 10.1002/hep.24744

  12. You have free access to this content
    Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

    Hepatology

    Volume 62, Issue 3, September 2015, Pages: 932–954, AASLD/IDSA HCV Guidance Panel

    Version of Record online : 4 AUG 2015, DOI: 10.1002/hep.27950

  13. Novel Therapeutic Approaches for Hepatitis C

    Clinical Pharmacology & Therapeutics

    Volume 95, Issue 1, January 2014, Pages: 78–88, JS Au and PJ Pockros

    Version of Record online : 19 DEC 2013, DOI: 10.1038/clpt.2013.206

  14. Direct-acting antivirals for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Janus C Jakobsen, Emil Eik Nielsen, Joshua Feinberg, Kiran Kumar Katakam, Kristina Fobian, Goran Hauser, Goran Poropat, Snezana Djurisic, Karl Heinz Weiss, Milica Bjelakovic, Goran Bjelakovic, Sarah Louise Klingenberg, Jian Ping Liu, Dimitrinka Nikolova, Ronald L Koretz and Christian Gluud

    Published Online : 18 SEP 2017, DOI: 10.1002/14651858.CD012143.pub3

  15. You have free access to this content
    Poster Session 1: Stem Cell Biology; Therapeutics: New Agents (not approved, phase 2–3)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 544A–574A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28216

  16. You have free access to this content
    Effectiveness of sofosbuvir-based regimens in genotype 1 and 2 hepatitis C virus infection in 4026 U.S. Veterans

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 5, September 2015, Pages: 559–573, L. I. Backus, P. S. Belperio, T. A. Shahoumian, T. P. Loomis and L. A. Mole

    Version of Record online : 26 JUN 2015, DOI: 10.1111/apt.13300

  17. You have free access to this content
    Poster Session II (Abstracts 730 – 1194)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 361–601,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28798

  18. You have free access to this content
    Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results

    Hepatology

    Volume 49, Issue 6, June 2009, Pages: 1838–1846, Bruce R. Bacon, Mitchell L. Shiffman, Flavia Mendes, Reem Ghalib, Tarek Hassanein, Giuseppe Morelli, Shobha Joshi, Kenneth Rothstein, Paul Kwo and Norman Gitlin

    Version of Record online : 2 FEB 2009, DOI: 10.1002/hep.22871

  19. You have free access to this content
    Adenosine kinase is a key determinant for the anti-HCV activity of ribavirin

    Hepatology

    Volume 58, Issue 4, October 2013, Pages: 1236–1244, Kyoko Mori, Osamu Hiraoka, Masanori Ikeda, Yasuo Ariumi, Akiko Hiramoto, Yusuke Wataya and Nobuyuki Kato

    Version of Record online : 19 AUG 2013, DOI: 10.1002/hep.26421

  20. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27516